Calabrese, M., Chaput, N., Rey, M., Jouniaux, J., Aglave, M., Cassard, L., Droin, N., Naigeon, M., Gavira, J., Bani, M. A., Escudier, B., Albiges, L., Flippot, R. (2026). Circulating angiogenic–myeloid cytokine axis to predict benefit from first-line immune-checkpoint inhibitor combinations in metastatic clear cell renal cell carcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.550